Literature DB >> 21814877

Rasch analysis in the development of a simplified version of the National Eye Institute Visual-Function Questionnaire-25 for utility estimation.

Jonathan W Kowalski1, Anne M Rentz, John G Walt, Andrew Lloyd, Jeff Lee, Tracey A Young, Wen-Hung Chen, Neil M Bressler, Paul Lee, John E Brazier, Ron D Hays, Dennis A Revicki.   

Abstract

PURPOSE: Preference-based health measures value how people feel about the desirability of a health state. Generic measures may not effectively capture the impact of vision loss from ocular diseases. Disease-targeted measures could address this limitation. This study developed a vision-targeted health state classification system based on the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25).
METHODS: Secondary analysis of NEI VFQ-25 data from studies of patients with central (n = 932)- and peripheral-vision loss (n = 2,451) were used to develop a health state classification system. Classical test theory and Rasch analyses were used to identify a smaller set of NEI VFQ-25 items suitable for the central- and peripheral-vision-loss groups.
RESULTS: Rasch analysis of the NEI VFQ-25 items using the peripheral vision-loss data indicated that 11 items fit a unidimensional model, while 14 NEI VFQ-25 items fit using the central-vision-loss data. Combining peripheral-vision-loss data and central-vision-loss data resulted in 9 items fitting a unidimensional model. Six items covering near vision, distance vision, social vision, role difficulties, vision dependency, and vision-related mental health were selected for the health-state classification.
CONCLUSIONS: The derived health-state classification system covers relevant domains of vision-related functioning and well-being.

Entities:  

Mesh:

Year:  2011        PMID: 21814877     DOI: 10.1007/s11136-011-9938-z

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  36 in total

1.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

2.  Quality of life with visual acuity loss from diabetic retinopathy and age-related macular degeneration.

Authors:  Melissa M Brown; Gary C Brown; Sanjay Sharma; Jennifer Landy; Jeff Bakal
Journal:  Arch Ophthalmol       Date:  2002-04

3.  Development of the 25-item National Eye Institute Visual Function Questionnaire.

Authors:  C M Mangione; P P Lee; P R Gutierrez; K Spritzer; S Berry; R D Hays
Journal:  Arch Ophthalmol       Date:  2001-07

4.  Utility values and age-related macular degeneration.

Authors:  G C Brown; S Sharma; M M Brown; J Kistler
Journal:  Arch Ophthalmol       Date:  2000-01

5.  Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, and lens opacity: AREDS Report no. 14.

Authors:  Anne S Lindblad; Traci E Clemons
Journal:  Arch Ophthalmol       Date:  2005-09

6.  Rhinitis Symptom Utility Index (RSUI) in Chinese subjects: a multiattribute patient-preference approach.

Authors:  Phoebe S Y Lo; Michael C F Tong; Dennis A Revicki; Ching Chyi Lee; John K S Woo; Henry C K Lam; C Andrew van Hasselt
Journal:  Qual Life Res       Date:  2006-06       Impact factor: 4.147

7.  Health literacy and adherence to glaucoma therapy.

Authors:  Kelly W Muir; Cecile Santiago-Turla; Sandra S Stinnett; Leon W Herndon; R Rand Allingham; Pratap Challa; Paul P Lee
Journal:  Am J Ophthalmol       Date:  2006-08       Impact factor: 5.258

Review 8.  Age-related macular degeneration: economic burden and value-based medicine analysis.

Authors:  Melissa M Brown; Gary C Brown; Joshua D Stein; Zachary Roth; Joseph Campanella; George R Beauchamp
Journal:  Can J Ophthalmol       Date:  2005-06       Impact factor: 1.882

9.  Health- and vision-related quality of life among patients with ocular histoplasmosis or idiopathic choroidal neovascularization at enrollment in a randomized trial of submacular surgery: Submacular Surgery Trials Report No. 5.

Authors: 
Journal:  Arch Ophthalmol       Date:  2005-01

10.  US norms for six generic health-related quality-of-life indexes from the National Health Measurement study.

Authors:  Dennis G Fryback; Nancy Cross Dunham; Mari Palta; Janel Hanmer; Jennifer Buechner; Dasha Cherepanov; Shani A Herrington; Ron D Hays; Robert M Kaplan; Theodore G Ganiats; David Feeny; Paul Kind
Journal:  Med Care       Date:  2007-12       Impact factor: 2.983

View more
  15 in total

1.  Should linking replace regression when mapping from profile-based measures to preference-based measures?

Authors:  Peter M Fayers; Ron D Hays
Journal:  Value Health       Date:  2014-03       Impact factor: 5.725

2.  Vision-related Quality of Life in Glaucoma Suspect or Early Glaucoma Patients.

Authors:  Asem Alqudah; Steven L Mansberger; Stuart K Gardiner; Shaban Demirel
Journal:  J Glaucoma       Date:  2016-08       Impact factor: 2.503

Review 3.  The Role of Condition-Specific Preference-Based Measures in Health Technology Assessment.

Authors:  Donna Rowen; John Brazier; Roberta Ara; Ismail Azzabi Zouraq
Journal:  Pharmacoeconomics       Date:  2017-12       Impact factor: 4.981

4.  Development of a preference-based index from the National Eye Institute Visual Function Questionnaire-25.

Authors:  Anne M Rentz; Jonathan W Kowalski; John G Walt; Ron D Hays; John E Brazier; Ren Yu; Paul Lee; Neil Bressler; Dennis A Revicki
Journal:  JAMA Ophthalmol       Date:  2014-03       Impact factor: 7.389

5.  Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT.

Authors:  Philip Hykin; A Toby Prevost; Sobha Sivaprasad; Joana C Vasconcelos; Caroline Murphy; Joanna Kelly; Jayashree Ramu; Abualbishr Alshreef; Laura Flight; Rebekah Pennington; Barry Hounsome; Ellen Lever; Andrew Metry; Edith Poku; Yit Yang; Simon P Harding; Andrew Lotery; Usha Chakravarthy; John Brazier
Journal:  Health Technol Assess       Date:  2021-06       Impact factor: 4.014

6.  Utility Index and Patient-Reported Outcome Measures in Glaucomatous Patients Comparing with Normal Participants.

Authors:  Kulawan Rojananuangnit; Nuttawan Sudjinda
Journal:  Clin Ophthalmol       Date:  2021-02-25

7.  Development of a new Rasch-based scoring algorithm for the National Eye Institute Visual Functioning Questionnaire to improve its interpretability.

Authors:  Jennifer Petrillo; Neil M Bressler; Ecosse Lamoureux; Alberto Ferreira; Stefan Cano
Journal:  Health Qual Life Outcomes       Date:  2017-08-14       Impact factor: 3.186

8.  Psychometric validation of the Visual Function Questionnaire-25 in patients with diabetic macular edema.

Authors:  Andrew J Lloyd; Jane Loftus; Michelle Turner; Ginny Lai; Andreas Pleil
Journal:  Health Qual Life Outcomes       Date:  2013-01-24       Impact factor: 3.186

Review 9.  Health state utilities in patients with diabetic retinopathy, diabetic macular oedema and age-related macular degeneration: a systematic review.

Authors:  Edith Poku; John Brazier; Jill Carlton; Alberto Ferreira
Journal:  BMC Ophthalmol       Date:  2013-12-04       Impact factor: 2.209

Review 10.  The impact of a better-seeing eye and a worse-seeing eye on vision-related quality of life.

Authors:  Christoph Hirneiss
Journal:  Clin Ophthalmol       Date:  2014-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.